+86-571-8627 3270
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd.
9 YRS
Liaoning, China
CNY 6 Million
1332 m²
Less than 50 people
Main Products: Tenofovir Alafenamide Fumarate / N-Methyl-2-Sulfanylbenzamide / 6-Iodo-1H-Indazole / (E)-6-Iodo-3-[2-(Pyridin-2-yl)Ethenyl]-1-(Tetrahydro-2H-Pyran-2-yl)-1H-Indazole / 4-Chloro-7-Methoxyquinoline-6-Carboxamide / 4-Amino-3-Chlorophenol / 4-(4-Chloro-2-Thienyl)-2-Thiazolamine / 4-(4-Chlorothiophen-2-Yl)-5-(4-Cyclohexylpiperazin-1-Yl)Thiazol-2-Amine / 1-Cyclohexylpiperazine / Phenyl Hydrogen [(R)-1-(6-Anino-9H-Purin-9-Yl)Propan-2-Yloxy]Methylphosphonate / 4-(3-Fluoro-Benzyloxy)-Benzaldehyde / 4-Hydroxy-7-Phenoxy-3-Isoquinolinecarboxylic Acid Methyl Ester
Liaoning, China
ABOUT US
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd., established in the beautiful spring city of Jinan in 2015, is a national high-tech enterprise and a science and technology-based small and medium-sized enterprise in Shandong Province. The company has a highly specialized R & D technical team, with a total number of more than 30 people, of which the backbone technicians have more than 10 years of working experience in drug R & D and registration application. Familiar with policies, regulations, technical requirements and registration process in the field of drug R & D. The company has a 1200 square meter standardized R & D laboratory in Jinan, a pharmaceutical intermediate production base in Panjin, Liaoning, and cooperates with a number of pharmaceutical enterprises to carry out API production and DMF registration. Main business: 1. API R & D, registration and preparation related application 2. R & D, production and sales of key pharmaceutical intermediates 3. Customization and process optimization of innovative compounds and intermediates Technical platform: 1. API and key intermediates process development and Optimization Platform 2. Crystal form and particle size research platform 3. Impurity spectrum (including base poison, etc.) research platform 4. Reference preparation and standardization platform 5. Stability research platform 6. CTD format DMF file writing Xinke pharmaceutical adheres to the concept of "honest service, innovative development and benefiting mankind", is willing to sincerely cooperate with friends from all walks of life for common development, and is committed to becoming the best partner of API solutions for MAH holders!
Basic Information
Tax ID
91370100MA3BX80E9G
Country/Region
Liaoning, China
Year Established
2015
Registered Capital
CNY 6 Million
Business Type
CRO
Total Employees
Less than 50 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
The company cooperates with many pharmaceutical enterprises to carry out API production and DMF registration
PLANT LOCATION
COMPANY ALBUM
厂房大门
办公区域
办公区域
办公区域
生产车间
生产车间
生产车间
CERTIFICATES
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >